Art

J-GLOBAL ID：202102259808401262   Reference number：21A1993279

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy

癌治療のためのキメラ抗原受容体ナチュラルキラー(CAR-NK)細胞の設計とエンジニアリング【JST・京大機械翻訳】

Author (13)： Gong Ying (Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands) ,  Gong Ying (GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands) ,  Wolterink Roel G. J. Klein (Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands) ,  Wolterink Roel G. J. Klein (GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands) ,  Wolterink Roel G. J. Klein (Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal) ,  Wang Jianxiang (State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China) ,  Wang Jianxiang (National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China) ,  Bos Gerard M. J. (Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands) ,  Bos Gerard M. J. (GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands) ,  Bos Gerard M. J. (CiMaas BV, Maastricht, The Netherlands) ,  Germeraad Wilfred T. V. (Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands) ,  Germeraad Wilfred T. V. (GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands) ,  Germeraad Wilfred T. V. (CiMaas BV, Maastricht, The Netherlands)
Material： Journal of Hematology & Oncology (Web)
Volume： 14  Issue： 1  Page： 1-35  Publication year： 2021 
JST Material Number： U7517A  ISSN： 1756-8722  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Due to their efficient recogni...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A1993279&from=J-GLOBAL&jstjournalNo=U7517A") }}

Thesaurus term： *heredity ,  side effect ,  detection method ,  T cell ,  NK cell ,  adoptive immunotherapy ,  electroporation ,  cell transplantation
Semi thesaurus term： 導入遺伝子 ,  癌免疫療法 ,  癌患者 ,  *癌治療 ,  免疫細胞 ,  *キメラ抗原受容体 ,  サイトカイン放出症候群 , 【Automatic Indexing@JST】

Author keywords (5)： Cancer immunotherapy ,  Adoptive cell therapy ,  Chimeric antigen receptor ,  Natural killer cells ,  Genetic modification

JST classification (2)： Immunotherapy for tumors  (GE03035B) ,  Blood cell tumors(=neoplasms)  (GK04000M)

Reference (200)：

• N Engl J Med; Chimeric antigen receptor therapy; CH June, M Sadelain; 379; 1; 2018; 64-73; 10.1056/NEJMra1706169; citation_id=CR1
• Science.; Gene therapy comes of age; CE Dunbar, KA High, JK Joung, DB Kohn, K Ozawa, M Sadelain; 359; 6372; 2018; eaan4672; 10.1126/science.aan4672; citation_id=CR2
• Cancers (Basel); Mechanisms of resistance to NK cell immunotherapy; C Sordo-Bahamonde, M Vitale; 12; 4; 2020; 893; 10.3390/cancers12040893; citation_id=CR3
• Cell; The emerging landscape of immune cell therapies; EW Weber, MV Maus, CL Mackall; 181; 1; 2020; 46-62; 10.1016/j.cell.2020.03.001; citation_id=CR4
• Front Immunol; Influence of the tumor microenvironment on NK cell function in solid tumors; O Melaiu, V Lucarini, L Cifaldi, D Fruci; 10; 2020; 3038; 10.3389/fimmu.2019.03038; citation_id=CR5

Terms in the title (5)： 癌治療 ,  キメラ抗原受容体 ,  細胞 ,  設計 ,  エンジニアリング